false
Catalog
Treatment of Tobacco Use Disorder in Primary Care
Presentation
Presentation
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, Jill Williams, a professor of psychiatry at Rutgers University, discusses the treatment of tobacco use disorder in primary care. She highlights the various forms of clinical assessment, including the "Time to First Cigarette" measure, and evidence-based pharmacotherapies for tobacco use disorder treatment, such as nicotine replacement dosing. Williams emphasizes the role of counseling in increasing the success of quit attempts using the "Ask, Advise, and Refer" model for primary care. <br /><br />She explains that tobacco smoke exposure contains thousands of chemical toxins, some naturally occurring in the tobacco plant and others from the manufacturing process. Tobacco use disorder is associated with many major health consequences, including heart disease, lung disease, and cancer, as well as financial hardships and mental health issues.<br /><br />Williams also discusses the social justice aspect of tobacco use disorder, noting that smoking rates are higher in disadvantaged populations. She explains the safety and effectiveness of different pharmacological treatments, such as nicotine replacement therapy, varenicline, and bupropion. The video also explores the role of counseling, including telephone counseling and intensive counseling, in helping individuals quit smoking.<br /><br />Additionally, Williams discusses the role of e-cigarettes as a harm reduction alternative. She examines the evidence regarding their effectiveness in smoking cessation, emphasizing the importance of switching entirely to e-cigarettes to maximize health benefits.<br /><br />Overall, the video provides a comprehensive overview of the treatment options and strategies for tobacco use disorder in primary care.
Asset Subtitle
View the recorded presentation to attest that you have viewed the presentation in its entirety.
Keywords
tobacco use disorder
primary care
clinical assessment
counseling
smoking rates
pharmacological treatments
e-cigarettes
harm reduction
health benefits
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English